Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
publishDate:"[2000 TO 2009]"
journalStr:"Hepatology"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2000+TO+2009%5D%22&filter%5B%5D=journalStr%3A%22Hepatology%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2000+TO+2009%5D%22&filter%5B%5D=journalStr%3A%22Hepatology%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
Search /vufind/Search2/Results?filter%5B%5D=publishDate%3A%22%5B2000+TO+2009%5D%22&filter%5B%5D=journalStr%3A%22Hepatology%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
PubPharm (2)
1
Merimepodib, pegylated interferon, and ribavirin in genotype 1 chronic hepatitis C pegylated interferon and ribavirin nonrespondersThe METRO study (VX03-497-205) is registered with ClinicalTrials.gov (NCT00088504). The METRO study was funded by Vertex Pharmaceuticals Inc., the developer of MMPD. The authors had full access to the study data, and the corresponding author had final responsibility to prepare and submit the manuscript for publication.Potential conflict of interest: Dr. Lee reports receiving consulting fees from AstraZeneca Pharmaceuticals, Eli Lilly and Co., and Fibrogen Inc., and grant support from Bristol-Myers Squibb, Roche, Schering-Plough Corp. Siemens, and Vertex Pharmaceuticals; Dr. Lawitz, grant support from Abbott Laboratories Anadys Pharmaceuticals, Inc., Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline GlobeImmune Inc., Human Genome Sciences, Idenix Pharmaceuticals, Idera Pharmaceuticals Intarcia Therapeutics, Inc., Medarex Inc., Merck & Co., Inc., Novartis, Roche, sanofi-aventi
enthalten in:
Hepatology
| 2009
von
Itsui, Y.
|
Sakamoto, N.
|
Kakinuma, S.
| +13
Wird geladen...
2
Albinterferon alfa-2b dosed every two or four weeks in interferon-naïve patients with genotype 1 chronic hepatitis CThis study is registered on ClinicalTrials.gov (identifier NCT00115908; URL XML-LINK="SIMPLE" HREF="http: clinicaltrials.gov-ct2-show-NCT00115908?term=human- +genome+sciences&rank=2">http: clinicaltrials.gov-ct2-show- -NCT00115908?term=human+genome+sciences&rank=2&- #41;Potential conflict of interest: Dr. McHutchison is a consultant for and received grants from Anadys, Colsy Pharmaceutical Group, First Circle Medical, GlaxoSmithKline, Human Genome Sciences, Idenix Pharmaceuticals, Intarcia, Novartis, Pharmasset, Pfizer, Roche, Schering-Plough, Valeant Pharmaceuticals, Vertex Pharmaceuticals, and Wyeth. He received grants from Globe Immune, Medtronics, Salix Pharmaceuticals, and Sanofi-Aventis. He is also a consultant for Biolex, Epiphany Biosciences, InterMune Pharmaceuticals, National Genetics Institute, Peregrine, and United Therapeutics. Drs. Subramanian, Cronin and Pulkstenis own stock in Human Genome Sciences, Inc. Dr. Kaita is a consultant for, is on the speakers' bureau of, and received gran
enthalten in:
Hepatology
| 2008
von
Zeuzem, S.
|
Yoshida, E.
|
Benhamou, Y.
| +11
Wird geladen...
1
[1]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Erscheinungsjahr: 2000-2009
Filter aufheben
Zeitschrift: Hepatology
Medienart
2
Aufsätze
2
Gedruckte Aufsätze
Zeitschriftentitel
Hepatology
Erscheinungszeitraum
2000-2009
1
2009
1
2008
Erscheinungsjahr(e)
Von:
Bis:
Haven't found what you're looking for?
Wird geladen...